Reviva Pharma's schizophrenia drug succeeds in late-stage study

In this article:

Oct 30 (Reuters) - Reviva Pharmaceuticals Holdings said on Monday its experimental drug to treat adults with schizophrenia met the main goal of a late-stage study. (Reporting by Mariam Sunny in Bengaluru; Editing by Savio D'Souza)

Advertisement